Pre-Day: PharmAI Leaders Exchange

Tuesday June 2nd 2026 | 10.00am - 5.00pm

*** This session is not open to everyone. Scroll down to register your interest ***

Pivot from Proof of Concept to Proven ROI 

AI has moved beyond experimentation. Across biopharma, the question is no longer if AI can deliver value but where and how is value being delivered, how to deploy it at scale and embed it into core business and R&D workflows.  

The PharmAI Leaders Exchange brings together 30 senior decision makers for delivering measurable returns from AI investments. Through candid, closed-door discussions, participants will share practical lessons on moving beyond pilots and proof-of-concept initiatives toward enterprise deployment, robust governance, and sustained performance. 

PharmAI roundtable

Moderators

What to expect

Participants will leave with actionable perspectives on how to accelerate deployment, strengthen data foundations, align teams around measurable KPIs, and ultimately realize the full return on their AI investments.

Sessions will be moderated by senior industry leaders for open dialogue on successes, failures, and next steps.

Who should attend

This Exchange is designed exclusively for senior decision-makers responsible for setting strategy, allocating  resources and driving implementation.

Attendance is limited to Pharma leaders at Director level and above. 

Event format

The Leaders Exchange is structured around five interactive roundtables, each designed to enable peer-to-peer discussion and practical knowledge sharing in a small group setting.

This meeting will be conducted in a trusted environment using the Chatham House Rule. Participants can use the information received, but neither the identity nor the affiliation of the speakers can be revealed.  

What the conversation will focus on 

Achieving measurable ROI 

How organisations are defining value, aligning AI initiatives to strategic priorities, and demonstrating impact across discovery, development, medical, and commercial functions.

Going beyond proof of concept

What it takes to transition from promising pilots to production-grade solutions — including change management, resourcing, stakeholder alignment, and scaling infrastructure.

Deployment at scale

How to integrate AI into existing workflows, systems, and decision-making processes, and ensuring adoption across teams and functions. 

KPI setting and value tracking

How to define meaningful success metrics and establishing accountability frameworks that link AI initiatives to performance outcomes. 

Data quality, access and sharing

Addressing foundational challenges around data readiness, governance, interoperability, and cross-functional access that determine whether AI efforts succeed or stall.

Register your interest

Please be aware that there are only a limited amount of places available. Attendance is limited to senior Pharma leaders directly involved in the strategy, implementation or oversight of AI initiatives within Pharma companies.

All registrations will be reviewed by the organising committee and approved participants will receive confirmation and event details.

Please complete the form below to express your interest in being considered for a place.

Please contact info@frontlinegenomics.com if you have any questions.